https://www.selleckchem.com/pr....oducts/amredobresib.
Machine learning (ML) algorithms can identify patients with cancer at risk of short-term mortality to inform treatment and advance care planning. However, no ML mortality risk prediction algorithm has been prospectively validated in oncology or compared with routinely used prognostic indices. To validate an electronic health record-embedded ML algorithm that generated real-time predictions of 180-day mortality risk in a general oncology cohort. This prognostic study comprised a prospective cohort of patients with outpatient oncolog
Like
Comment
Share
